Published: October 26, 2023
General
This important milestone is the culmination of the revitalization process that started in late 2022, when the pCPA became an independent, not‑for‑profit organization. “Without a doubt, this has been a landmark year for the organization,” says Mitch Moneo, chair of the pCPA Board of Directors. “The pCPA has a long record of achievements, and its new structure establishes the foundation for the pCPA to move forward as both a proactive and responsive stand-alone organization, more readily able to adapt to a changing environment.”
The report highlights our organization's journey from becoming incorporated, to establishing a dynamic leadership team, to appointing our first chief executive officer, Douglas Clark. Doug brings a wealth of experience and expertise to the organization. Combined with a skilled and dedicated team, this new leadership will propel the organization to new heights while staying true to our core objectives to:
- Increase access to relevant and cost-effective treatments
- Achieve consistent and lower drug costs
- Reduce duplication and optimize resource utilization
- Improve consistency in funding decisions
Check out the inaugural report to learn more about the last year and what the future holds for the pCPA.
